Literature DB >> 16672546

The effects of HIV infection on oral mucosal immunity.

S J Challacombe1, J R Naglik.   

Abstract

Oral mucosal infections, especially candidiasis, are a feature of HIV disease, suggesting that compromised mucosal immunity within the oral cavity is a consequence of the viral infection. However, how this mucosal immunity is compromised and at what stage of HIV infection this occurs are unclear. Better understanding of the protection of the oral cavity against infection has allowed us to gain some insight into the local consequences of HIV infection. From a humoral perpective, IgA2 subclasses are reduced in HIV infection in saliva, and total secretory IgA levels are reduced in later disease. Similarly, mucosal antibody responses appear near normal in early HIV infection but reduced in AIDS. There is now convincing evidence that salivary IgA can be neutralizing to HIV 1 and HIV 2, as well as block epithelial transmigration. Oral cellular immunity is also affected by HIV infection. Transmission of HIV from one oral cell type to another appears to be confirmed by work showing that HIV can bind to or infect epithelial cells, Langerhans cells, and other mucosal cells. CXCR4 tropic (via GalCer and CXCR4) and dual tropic HIV strains have been shown to be able to infect normal human oral keratinocytes (NHOKs), and infectious HIV virions can also be conveyed from NHOKs to activated peripheral blood lymphocytes, suggesting a potential role of oral epithelial cells in the transmission of HIV infection. There is evidence of up-regulation of various receptors, including HIV receptors, on the surface of oral epithelium, and the epithelium may become more permeable. HIV may exploit this antigen uptake mechanism to cross epithelial barriers during co-infection with damage-inducing pathogens such as Candida. Immune responsiveness to many of the co-pathogens associated with HIV has been demonstrated to depend on a family of innate recognition molecules, known as Toll-like receptors (TLR), and recognition of a single pathogen can involve activation of multiple TLRs. Consequently, TLR-pathogen interactions could play an indirect but major role in regulating HIV-associated disease in the oral cavity. Thus, HIV infection appears to have both direct and indirect effects on oral mucosal immunity, affecting both cellular and humoral immunity as well as both specific and innate immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672546     DOI: 10.1177/154407370601900107

Source DB:  PubMed          Journal:  Adv Dent Res        ISSN: 0895-9374


  24 in total

1.  Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  Wipawee Nittayananta; Marisa Kemapunmanus; Korntip Amornthatree; Sineepat Talungchit; Hutcha Sriplung
Journal:  J Oral Pathol Med       Date:  2012-06-09       Impact factor: 4.253

Review 2.  Oral innate immunity in HIV infection in HAART era.

Authors:  Wipawee Nittayananta; Renchuan Tao; Lanlan Jiang; Yuanyuan Peng; Yuxiao Huang
Journal:  J Oral Pathol Med       Date:  2015-01-31       Impact factor: 4.253

Review 3.  Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2010-08       Impact factor: 4.388

4.  Innate immunity including epithelial and nonspecific host factors: workshop 1B.

Authors:  A Weinberg; J R Naglik; A Kohli; S M Tugizov; P L Fidel; Y Liu; M Herzberg
Journal:  Adv Dent Res       Date:  2011-04

5.  An IL-17F.S65L Knock-In Mouse Reveals Similarities and Differences in IL-17F Function in Oral Candidiasis: A New Tool to Understand IL-17F.

Authors:  Chunsheng Zhou; Leticia Monin; Rachael Gordon; Felix E Y Aggor; Rami Bechara; Tara N Edwards; Daniel H Kaplan; Sebastien Gingras; Sarah L Gaffen
Journal:  J Immunol       Date:  2020-06-29       Impact factor: 5.422

6.  Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  W Nittayananta; K Amornthatree; M Kemapunmanus; S Talungchit; H Sriplung
Journal:  Oral Dis       Date:  2013-05-30       Impact factor: 3.511

7.  Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.

Authors:  Luciana Pomarico; Daniella Ferraz Cerqueira; Rosangela Maria de Araujo Soares; Ivete Pomarico Ribeiro de Souza; Gloria Fernanda Barbosa de Araujo Castro; Sigmund Socransky; Anne Haffajee; Ricardo Palmier Teles
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-08

Review 8.  Oral manifestations associated with HIV infection.

Authors:  Mostafa Nokta
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

9.  Normal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes.

Authors:  Jessica V Pierce; Daniel Dignard; Malcolm Whiteway; Carol A Kumamoto
Journal:  Eukaryot Cell       Date:  2012-11-02

10.  Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  Wipawee Nittayananta; Marisa Kemapunmanus; Supaporn Yangngam; Sineepat Talungchit; Hutcha Sriplung
Journal:  J Oral Pathol Med       Date:  2012-11-06       Impact factor: 4.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.